The Million Women Study
Lead Research Organisation:
University of Oxford
Department Name: Clinical Medicine
Abstract
We actively involve participants and the public in various stages of our research, using focus groups when designing questionnaires and including lay members in our Steering Committees. The views of members of the public are invited via our study websites and free-phone lines. To date, we have responded to over 6000 enquiries.
We regularly update our websites, summarizing our results in lay language, and frequently discuss our work at public meetings. We will continue to disseminate our findings widely, since our research is aimed primarily at providing reliable information on modifiable factors that directly affect the health of the public.
We regularly update our websites, summarizing our results in lay language, and frequently discuss our work at public meetings. We will continue to disseminate our findings widely, since our research is aimed primarily at providing reliable information on modifiable factors that directly affect the health of the public.
Technical Summary
The Million Women Study is the world largest longitudinal study of the health of women, worldwide. In 1996-2001 1.36 million UK women were recruited through NHS breast screening centres. In the eligible age range, 50-64 years, they include ~25% of all UK women; and, in the recruitment areas, ~50% of the general population and ~70% of those screened. To join the study women completed a questionnaire about a range of social, demographic, personal and lifestyle factors and gave signed consent for follow-up.
The average age was 56 then, and is now 65. Two postal re-surveys have been done collecting information on a wide range of variables. Some 10 million women-years of follow-up have already accrued, with more than 40,000 deaths and 2 million admissions to NHS hospitals. Over 99% of the survivors are still being routinely followed for cause-specific deaths and hospital admissions. Further details and study questionnaires are at www.millionwomenstudy.org.
The Million Women Study was set up to provide reliable information about the major causes of disability and death among women. The long-term plan is to continue following the cohort until the average age is 80 at least, focusing on changing public health issues as women age. Initial emphasis was on hormone replacement therapy and breast cancer, because one third used HRT and breast cancer is the most common cause of death among women in their 50s.
For women in their 60s, however, heart disease and stroke become the leading causes of disability and death. Obesity, alcohol, smoking, physical inactivity, body size at various ages, and other factors have been linked to the risk of women developing vascular disease. There is concern about the rapid rise in obesity, not only for vascular disease, but for many non-fatal conditions. There is also concern about the effects of the rising consumption alcohol and there is a need to characterize the net effect of moderate intakes on the health of women.
In the next 5 years, and beyond, the Million Women Study can provide uniquely reliable evidence about the changing role of obesity, drinking, smoking and many other factors in vascular and other major diseases among women.
The average age was 56 then, and is now 65. Two postal re-surveys have been done collecting information on a wide range of variables. Some 10 million women-years of follow-up have already accrued, with more than 40,000 deaths and 2 million admissions to NHS hospitals. Over 99% of the survivors are still being routinely followed for cause-specific deaths and hospital admissions. Further details and study questionnaires are at www.millionwomenstudy.org.
The Million Women Study was set up to provide reliable information about the major causes of disability and death among women. The long-term plan is to continue following the cohort until the average age is 80 at least, focusing on changing public health issues as women age. Initial emphasis was on hormone replacement therapy and breast cancer, because one third used HRT and breast cancer is the most common cause of death among women in their 50s.
For women in their 60s, however, heart disease and stroke become the leading causes of disability and death. Obesity, alcohol, smoking, physical inactivity, body size at various ages, and other factors have been linked to the risk of women developing vascular disease. There is concern about the rapid rise in obesity, not only for vascular disease, but for many non-fatal conditions. There is also concern about the effects of the rising consumption alcohol and there is a need to characterize the net effect of moderate intakes on the health of women.
In the next 5 years, and beyond, the Million Women Study can provide uniquely reliable evidence about the changing role of obesity, drinking, smoking and many other factors in vascular and other major diseases among women.
Organisations
Publications

Floud S
(2017)
Disability and participation in breast and bowel cancer screening in England: a large prospective study.
in British journal of cancer

Sweetland S
(2009)
Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study.
in BMJ (Clinical research ed.)

Key T
(2019)
Erratum: Foods, macronutrients and breast cancer risk in postmenopausal women: a large UK cohort
in International Journal of Epidemiology

Gathani T
(2014)
Ethnic differences in breast cancer incidence in England are due to differences in known risk factors for the disease: prospective study.
in British journal of cancer

Stevens RJ
(2009)
Factors associated with incident and fatal pancreatic cancer in a cohort of middle-aged women.
in International journal of cancer

Couto E
(2008)
Family history and breast cancer tumour characteristics in screened women.
in International journal of cancer

Allen NE
(2011)
Fluid intake and incidence of renal cell carcinoma in UK women.
in British journal of cancer

Liu B
(2008)
Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study.
in BMJ (Clinical research ed.)

Travis RC
(2010)
Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study.
in Lancet (London, England)

Green J
(2011)
Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk.
in The Lancet. Oncology
Guideline Title | prescribing HRT |
Description | HRT Prescribing advice |
Geographic Reach | Multiple continents/international |
Policy Influence Type | Citation in clinical guidelines |
Impact | HRT prescribing has fallen substantially in the UK and worldwide and this has been followed by a fall in the number of incident cases of breast cancer. Current scientific opinion is that the two are causally related, and that the fall in (unnecessary) prescribing of HRT has prevented tens of thousands of breast cancer cases worldwide. The guidelines no longer advise prescripion of HRT as first-line treatment for postmenopausal osetoposis and this has controbuted to the very rapid rise in prescribing of other agents, notably of oral bisphosphonates. The long-term efficacy and effects of these agents is not clear and further research is underway. |
Description | Post-operative VTE risk |
Geographic Reach | Local/Municipal/Regional |
Policy Influence Type | Citation in clinical reviews |
Description | advisory positions- please see Awards section. |
Geographic Reach | National |
Policy Influence Type | Participation in advisory committee |
Description | Shiftwork and disease (HSE) 2009-2015 |
Amount | £530,000 (GBP) |
Organisation | Health and Safety Executive (HSE) |
Sector | Public |
Country | United Kingdom |
Start | 06/2009 |
End | 12/2015 |
Title | Record linkage of large epidemiological data-bases |
Description | We were the first group in England to successfully link a large database (The Million Women Study) with HES data. We have in 2014 obtained linkage to the primary care data in CPRD (and plan to link to equivalent datsets in Scotland) We have linked MWS data to that held by the NHS Cancer Screening Programmes. Our research staff have developed methods for reliable use of linked data in large epidemiological studies, including data dictionaries,derived variables and outcomes adjudication; we are working in collaboration with other UK cohorts. We have applied to link MWS data with that in UK Biobank. We have taken part in conferences on e-health research. |
Type Of Material | Technology assay or reagent |
Year Produced | 2009 |
Provided To Others? | Yes |
Impact | Many groups have consulted us about record linkage, and we regularly assist them in such work. We are working with UK biobank on validation studies on use of linked data eg for stroke and for neurodegenerative disease. Linkage with Cancer Screening will allow us to feed back information eg on characteristics of screened women which has the potential to improve service. |
Title | Web-based questionnaires |
Description | We have developed web-based questionnaires on diet and physical activity. |
Type Of Material | Technology assay or reagent |
Year Produced | 2009 |
Provided To Others? | Yes |
Impact | UK Biobank has incorporated our web-questionnaires into their work. |
Title | Oxford WebQ |
Description | Online dietary questionnaire with automatic data coding by nutrient values. |
Type Of Material | Database/Collection of data |
Year Produced | 2012 |
Provided To Others? | Yes |
Impact | The WebQ has been used by us and by UK Biobank to collect repeated measures of dietary intake for our large cohort studies. Data from the webQ will shortly be available for research use. Experiwence in using the webQ in UK Biobank has led to development of other online questionnaires, and so a new model of data collection in ongoing cohorts. |
Description | BHFCRE |
Organisation | University of Oxford |
Department | BHF Centre of Research Excellence |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Cardiovascular research on Million Women Study and EPIC-Oxford cohorts contributes to the Population health component of the current round of funded research (2014-); CEU staff named as senior PIs for the BHFCRE; collaborative research projects with other Oxford groups within BHFCRE underway and planned. |
Collaborator Contribution | Collaboration on CVD research; opportunities for funding for specific projects and fellowships. |
Impact | Funding for feasibility study of genetic and environmental risk factors for aortic stenosis [Million Women Study]. |
Start Year | 2011 |
Description | CTSU |
Organisation | Medical Research Council (MRC) |
Department | MRC/Cancer Research UK/BHF Clinical Trial Service Unit & Epidemiological Studies Unit |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Collaboration on a number of analyses of Million Women Study Data, particularly with respect to vascular disease epidemiology and statistical methods. |
Collaborator Contribution | Intellectual imput |
Impact | Several papers jointly written. Multidisciplinary - statistics and cardiovascular epidemiology |
Start Year | 2006 |
Description | DementiasPlatformUK |
Organisation | MRC Dementias Platform UK |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Contributing cohort with particular interest/expertise in outcomes adjudication for research using electronic health records. |
Collaborator Contribution | Collaboration on outcomes adjudication work -also includes UK Biobank and UK-wide neurodegenerative disease outcomes groups [including NOWG] |
Impact | None yet; platform launched October 2014 |
Start Year | 2014 |
Description | Economic costs of obesity |
Organisation | University of Oxford |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Epidemiological expertise Data on obesity and use of primary and secondary care in the Million women Study cohort |
Collaborator Contribution | Expertise in health economics and health policy |
Impact | None yet |
Start Year | 2014 |
Description | NSHD |
Organisation | Medical Research Council (MRC) |
Department | National Survey of Health and Development (NSHD) |
Country | United Kingdom |
Sector | Public |
PI Contribution | Linkage of anthropometric and other data from MWS to data held by NSHD; analysis of comparison between measured and reported values |
Collaborator Contribution | Linkage of measured values from NSHD to MWS data Intellectual input for publication |
Impact | Publication (Cairns 2011) |
Start Year | 2010 |
Description | Oxford WebQ |
Organisation | UK Biobank |
Country | United Kingdom |
Sector | Charity/Non Profit |
PI Contribution | Collaborative development of online dietary questionnaire (the Oxford WebQ); in use by UKBiobank and MWS; MWS programmer led development. |
Collaborator Contribution | Programming and scientific input. |
Impact | Methods and validation publication: Liu et al 2011 Data collected in UK biobank for 200,000 particpants Within MWS for 20,000 participants |
Start Year | 2007 |
Description | UKBiobank |
Organisation | UK Biobank |
Country | United Kingdom |
Sector | Charity/Non Profit |
PI Contribution | Membership of steering committee and International Scientific Advisory Board Contribution of MWS data to UK Biobank outcomes validation working group: stroke, neurodegenerative disease Development of online questionnaires on diet (the Oxford WebQ, developed in CEU and used by UKB) ,occupation, cognitive function. |
Collaborator Contribution | UK Biobank financial and staff support for outcomes validation and online questionnaires is relevant both to UKB and to our large epidemiological studies. |
Impact | The Oxford WebQ diet questionnaire [enquiries: krys.baker@ceu.ox.ac.uk]. |
Start Year | 2011 |
Description | genotyping |
Organisation | McGill University |
Country | Canada |
Sector | Academic/University |
PI Contribution | Blood samples for genotyping collected by Million Women Study. Data analysed by Million Women Study. |
Collaborator Contribution | DNA extraction and genotyping. |
Impact | 3 publications on joint effects of genetic and environmental risk factors for breast cancer (Travis et al, 2010; Reeves etal, 2010 and 2011). |
Start Year | 2006 |
Description | genotyping |
Organisation | National Genotyping Center (CNG) |
Country | France |
Sector | Academic/University |
PI Contribution | Blood samples for genotyping collected by Million Women Study. Data analysed by Million Women Study. |
Collaborator Contribution | DNA extraction and genotyping. |
Impact | 3 publications on joint effects of genetic and environmental risk factors for breast cancer (Travis et al, 2010; Reeves etal, 2010 and 2011). |
Start Year | 2006 |
Description | 6th International Workshop on Causes of Childhood Leukemia - Gerry Kendall |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | 20/11/2019 6th International Workshop on Causes of Childhood Leukemia (BfS, Munich) "An update on childhood cancer and natural radiation in Great Britain" |
Year(s) Of Engagement Activity | 2019 |
Description | Clinical Epidemiology Group Meeting, Harvard - Sarah Floud |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | 15th March 2019: Clinical Epidemiology Group Meeting, Harvard TH Chan School of Public Health, USA "Risk factors for dementia: UK Million Women Study" |
Year(s) Of Engagement Activity | 2019 |
Description | Course on Radiation Epidemiology and Dosimetry - Gerry Kendall |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | 12/09/2019 Course on Radiation Epidemiology and Dosimetry (NCI, Washington) "Cancer Risks from Natural Background Radiation and Radon" |
Year(s) Of Engagement Activity | 2019 |
Description | Green Templeton College Research Talks Symposium - Sarah Floud |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Other audiences |
Results and Impact | 7th June 2019: Green Templeton College Research Talks Symposium, University of Oxford, UK "What Can A Million Women Tell Us About Preventing Dementia?" |
Year(s) Of Engagement Activity | 2019 |
Description | I'm a scientist |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | Yes |
Geographic Reach | National |
Primary Audience | Schools |
Results and Impact | Both researchers engaged with hundreds of children on a wide range of topics. The researcher who won the award received a prize which is being used to develop educational materials about science for schools. Not measurable. |
Year(s) Of Engagement Activity | 2011,2012 |
Description | Invited lecture: Breast Cancer as a Global Health Concern - Toral Gathani |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Professional Practitioners |
Results and Impact | Invited lecture: Breast Cancer as a Global Health Concern: National Cancer Registration Service at PHE Seminar Series, London 2019 |
Year(s) Of Engagement Activity | 2019 |
Description | Invited speaker at the International Centre for Lifecourse Studies in Society and Health Annual Centre Day - Sarah Floud |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | Invited speaker at the International Centre for Lifecourse Studies in Society and Health Annual Centre Day |
Year(s) Of Engagement Activity | 2018 |
Description | Media coverage/press interviews for HRT paper - Gillian Reeves |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Media coverage/press interviews for HRT paper 29th August 2019 , Interviews with BBC news, BBC Radio London Beral V, Peto R, Pirie K, Reeves GK, for the Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormonal therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. Lancet 2019; 394: 1159-1168. |
Year(s) Of Engagement Activity | 2019 |
Description | Media: general |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | Many of our findings are disseminated widely in the media and to policy makers, as our findings are often relevant to public health - eg the health consequences of alcohol consumption and of obesity in women; the effects of HRT; physical activity and vascular diseases Our finging on HRT and alcohol have affected policy. |
Year(s) Of Engagement Activity | 2006,2007,2008,2009,2010,2011,2012,2013,2014,2015,2016,2017 |
Description | NDPH Health Annual Symposium - Gillian Reeves |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Other audiences |
Results and Impact | 27th March 2019, Nuffield Department of Population Health Annual Symposium, Said Business School. "Breast cancer research in the Million Women Study". |
Year(s) Of Engagement Activity | 2019 |
Description | Oxford Martin School, Oxford Seminar Series on Older Women's Health - Sarah Floud |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Other audiences |
Results and Impact | 6th November 2019: Oxford Martin School, Oxford Seminar Series on Older Women's Health, University of Oxford, UK "Risk factors for dementia in the Million Women Study" |
Year(s) Of Engagement Activity | 2019 |
Description | Oxford-PKU Joint Symposium on Precision Medicine - Gillian Reeves |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Other audiences |
Results and Impact | 19th September 2019, Oxford-PKU Joint Symposium on Precision Medicine, Big Data Institute, University of Oxford. "The Million Women Study: key findings" |
Year(s) Of Engagement Activity | 2019 |
Description | Participated in an expert round table on ageism in breast cancer - Isobel Barnes |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Other audiences |
Results and Impact | In April 2019 Isobel participated in an expert round table on ageism in breast cancer hosted by the International Longevity Centre UK. |
Year(s) Of Engagement Activity | 2019 |
Description | Plenary, Nuffield Department of Population Health Symposium - Sarah Floud |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Other audiences |
Results and Impact | 9th January 2020: Plenary, Nuffield Department of Population Health Symposium, University of Oxford, UK "Dispelling dementia myths: answers from a million women" |
Year(s) Of Engagement Activity | 2020 |
Description | Prescribing policy: HRT |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | Yes |
Geographic Reach | National |
Primary Audience | Health professionals |
Results and Impact | Our results have been summarized by the MHRA and have informed their prescribing guidelines both on use of HRT for menopause and on treatment of postmenopausal osteoporosis Prescribing of HRT has declined and the incidence of breast cancer has declined in the UK and in other 'developed' countries where HRT was widely prescribed. |
Year(s) Of Engagement Activity | 2006,2007,2008,2009 |
Description | Presented Epidemiology session as part of the annual science week to year 5 and 6 students at Cutteslowe Primary School - Isobel Barnes |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Schools |
Results and Impact | presented epidemiology session as part of the annual science week to year 5 and 6 students at Cutteslowe Primary School |
Year(s) Of Engagement Activity | 2018 |
Description | Presented sessions on epidemiology to Year 5 children as part of the annual science week - Isobel Barnes |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Schools |
Results and Impact | Presented sessions on epidemiology to Year 5 children as part of the annual science week for Oxford primary schools in March 2019. |
Year(s) Of Engagement Activity | 2019 |
Description | Recruited participants to and convened first meeting of the Million Women Study Participant Panel - Sarah Floud |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | I recruited participants to and convened first meeting of the Million Women Study Participant Panel on 1st October 2019 |
Year(s) Of Engagement Activity | 2019 |
Description | Represented CEU at The Oxford Open Doors - Isobel Barnes |
Form Of Engagement Activity | Participation in an open day or visit at my research institution |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | Represented CEU at The Oxford Open Doors September in September 2019 |
Year(s) Of Engagement Activity | 2019 |
Description | Represented the Unit at NDPH Open Doors Oxford event - Isobel Barnes |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | represented the unit at NDPH Open Doors Oxford event |
Year(s) Of Engagement Activity | 2018 |
Description | Schools Open Day - Isobel Barnes |
Form Of Engagement Activity | Participation in an open day or visit at my research institution |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Schools |
Results and Impact | Represented CEU at the Oncology School Open Day in April 2019 |
Year(s) Of Engagement Activity | 2019 |
Description | Schools Open Day - Kezia Gaitskell |
Form Of Engagement Activity | Participation in an open day or visit at my research institution |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Schools |
Results and Impact | Audience: 165 school pupils of GCSE/A level age, with teachers (and some parents) Activity: We organised and led an interactive table-top game (originally developed by Prof Ruth Travis), which explained the principles of epidemiology, and the practicalities of performing and analysing a cohort study. |
Year(s) Of Engagement Activity | 2019 |
Description | Science Fairs |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | Research staff are active in having stalls with interactive games etc to help people understand our work and what it means at public Science Fairs eg: Science in your world' Science Week 2013, Oxford: epidemiology game, discussions on cohort studies Cancer Research UK Interactive Science Fair, Oxford: personalised medicine Bright Sparks Brighton Science Festival 2014: obesity and cancer stall/activities MRC Centenary Celebration Science Fair, London: epidemiology stall and activity 'Science Lates' event, Science Museum, London, September 2015 Oxford Science Festival, July 2016 WCRF Support Event, Worcester College, 2017 ScienceOxford 'Famelab', February 2017 Stalls and games provoke interest and engagement at the time. Further impact unknown. |
Year(s) Of Engagement Activity | 2012,2013,2014,2015,2016,2017 |
Description | Society for Social Medicine and Population Health and International Epidemiology Association European Congress meeting - Sarah Floud |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Other audiences |
Results and Impact | 5th September 2019: Oral presentation, Society for Social Medicine and Population Health and International Epidemiology Association European Congress Joint Annual Scientific Meeting, University College Cork, Ireland "Cognitive and social activities and long-term risk of dementia in UK women" |
Year(s) Of Engagement Activity | 2019 |
Description | UK Interdisciplinary Breast Cancer Symposium - Gillian Reeves |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Other audiences |
Results and Impact | 27th-28th January 2020. UK Interdisciplinary Breast Cancer Symposium. International Convention centre, Birmingham, UK. |
Year(s) Of Engagement Activity | 2020 |
Description | consultative conference arranged by Parkinson's UK - Sarah Floud |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Other audiences |
Results and Impact | Attended a consultative conference arranged by Parkinson's UK: 10th May 2019: Parkinson's UK Workshop "Developing data driven project to deliver health benefits for people affected by Parkinson's |
Year(s) Of Engagement Activity | 2019 |
Description | science open days |
Form Of Engagement Activity | Participation in an open day or visit at my research institution |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | Open days held at the Cancer Research UK Oxford Research Centre are attended by MWS staff; our posters present both cancer and some non-cancer work to local supporters and the general public . Not measured. |
Year(s) Of Engagement Activity | 2011,2012,2013,2014,2015,2016,2017 |
Description | talks to participants |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | MWS researchers speak about the study at meetings of interested local groups (eg Women's Institute), including study participants. 2015/16 several researchers have spoken to the Nuffield Department of Population Health participant panel. November 2016 one of researchers gave two lectures about the MWS to U3A meeting in Haddenham, Bucks Not measured. |
Year(s) Of Engagement Activity | 2008,2009,2010,2011,2012,2013,2014,2015,2016,2017 |